Amniocentesis Needle Market Development | Industry Report 2022

According to the new market research report Amniocentesis Needle Market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Factors driving the growth of this market include the high accuracy of amniocentesis, increase in the median age of first-time motherhood, and increasing prevalence of congenital disorders.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18541768

Use of amniocentesis needles in amniocentesis procedures drives the global 100–150 mm needles market

This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.

By procedure, the market is segmented into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is expected to account for the largest share of the global amniocentesis needles market. Increasing burden of chromosomal disorders, increasing maternal age & BMI, and high reliability of the amniocentesis technique are the major factors responsible for the dominant share of this segment.

Hospitals are estimated to command the largest share of the market during the forecast period
On the basis of end user, the amniocentesis needles market is categorized into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to account for the largest share of the global amniocentesis needles market during the forecast period. The presence of expert personnel and advanced medical equipment in hospitals are the key factors driving the growth of this end-user segment.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18541768

The global amniocentesis needles market is dominated by North America, followed by Europe. North America will continue to dominate the global amniocentesis needles market during the forecast period. Factors such as the rising government initiatives and increasing healthcare expenditure are driving the growth of the amniocentesis needles market in this region.

Amniocentesis Needle Market Size, Share, Trends and Forecast 2022

According to the new market research report Amniocentesis Needle Market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. The global amniocentesis needles market covers products that are used to withdraw amniotic fluid into a syringe. These needles are of special material and have a long tip which is visible under ultrasound. These needles are primarily used to perform amniocentesis, an invasive prenatal diagnostic procedure carried out in the second trimester of pregnancy. Factors driving the growth of this market include high reliability of amniocentesis, growth in the median age of first-time motherhood, and the heavy burden of congenital disorders.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=18541768 

Amniocentesis is considered as the gold standard for confirming positive screening results of screening tests. This test is recommended as a confirmatory diagnostic test by health systems across the globe on account of the high levels of accuracy and specificity, in spite of a small possibility of a risk associated with the procedure.

On the basis of type, the amniocentesis needles market is categorized into needles of length 100–150 mm, larger than 150 mm, and smaller than 100 mm. The 100–150 mm segment is expected to grow at the fastest rate during the forecast period. The common use of these needles on account of their optimal length as compared to needles of other lengths is the main factor contributing to the high growth rate of this segment.

By procedure, the market is categorized into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is estimated to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the high demand for amniocentesis as a confirmatory invasive prenatal diagnostic procedure.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18541768

By end user, the amniocentesis needles market is classified into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to grow at the fastest rate during the forecast period. The developing healthcare infrastructure and the rising number of diagnostic tests in hospitals are driving the demand for amniocentesis needles in this end-user segment.

The amniocentesis needles market is geographically segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to have the highest growth rate due to the growing number of initiatives to promote prenatal diagnosis, rapid economic development, and increasing healthcare expenditure.

Given the immense opportunities in accurate prenatal diagnosis, market leaders and emerging players are increasingly focusing on the market in the segments mentioned above to increase their revenues and are also looking to expand their reach to emerging economies.

Know more: https://www.marketsandmarkets.com/PressReleases/amniocentesis-needle.asp